Strategic Management and Sustainability: AstraZeneca Company Report

This report delves into the realm of strategic management and sustainability, using AstraZeneca as a prime example. It begins by defining strategic management and its importance in achieving a competitive edge, especially concerning environmental sustainability. The main body of the report examines AstraZeneca's core business strategies, focusing on its commitment to growth, innovation, and financial returns. It then analyzes the company's resources and capabilities, emphasizing how they align with its strategic objectives. Furthermore, the report explores AstraZeneca's approach to environmental sustainability, addressing the challenges and opportunities within the pharmaceutical industry. The report concludes by summarizing the key findings and emphasizing the importance of integrating sustainability into strategic decision-making for long-term success. The report also touches upon the theories and ways of thinking about gaining a competitive advantage. The report is a valuable resource for students studying business development and strategic management.

Strategic management and sustainability

TABLE OF CONTENTS
INTRODUCTION......................................................................................................................... 3
MAIN BODY................................................................................................................................ 3
Business strategies.................................................................................................................. 3
Resources and capabilities......................................................................................................5
Environmental sustainability....................................................................................................6
CONCLUSION............................................................................................................................. 8
REFERENCES............................................................................................................................ 9
Books and Journals................................................................................................................. 9
Online...................................................................................................................................... 9

INTRODUCTION
Strategic management refers to the policies and procedures that might be seeks for having
the competitive advantage along with the core for the environmentally sustainability. This
strategy might be give the full attention to the environmental and sustainability protection.
Astrazeneca is multinational pharmaceutical organization and it has the portfolio for various
disease products and also perhaps well-known for the developing Oxford Covid-19 vaccine.
This report explain about the key business strategies for the company along with their past five
year research. Along with the also explain about the resources and capabilities over the
company and aligned its resources and capabilities for their business strategies. Furthermore,
also examine about the organization that can implement the environmentally sustainability,
theories and ways for which thinking about becoming more competitive advantage.
MAIN BODY
Business strategies
Business strategy draws an outline of the actions a company do and decisions it make in
order to reach business’s desired goals and objectives. A business strategy defines the needs
and requirements of business which in turn will help in making appropriate decisions and lead to
the hiring new talents and allocating associated resources. It helps in making all the different
departments working within an organisation to work together and therefore support the direction
of the company. All the organisations follow different type of business strategy which is best
suited for their company’s business (Mahase, 2021). AstraZeneca is a company working in
pharmaceutical company and focus on strategy helping them grow and achieve leadership.
AstraZeneca today is building a business strategy to return to growth and attain scientific
leadership.
The company is committed to deliver great remedies to patients with the help of innovative
science and developing with commercialisation. Company’s vision is clear which is to be a

global pharmaceutical organisation. Some of the focused points in the company are to core
therapy areas, underpinned with the help of distinguishing science and therefore growing into
last stage pipeline. They are offering many attractive financial returns for the investors and the
company do not believe in diversification. The company announced their business strategy into
showing the high level of commitment for putting all the possible efforts and available resources
in platform for growth and other related projects (Holmberg-Wright, Hribar, and Tsegai, 2017).
As the company is moving on and transforming their business, they know that company’s
success is measured by quality of execution. The organisation is very confident into setting a
right path and being determinate into delivering best supply to patients and shareholders.
AstraZeneca’s strategy is to drive the on market growth into returning growth as they are
working in an industry where patent expires after some period of time and revenue declines.
The company is trying to progress on their future projects and completing their promise of
biologics portfolio. The company is looking forward to launch a flow of special care products
while balancing the company’s signature in primary care. AstraZeneca is trying to rebuilt the
R&D engine with the help of innovation and different forms of science. This is supported by
sending their teams to different location and thus, receiving better access to science clusters
present all around the globe. The company is trying to simplify the business, improving the
productivity and forming an organisational culture which will lead to long term success. The
organisation is ready to leverage their development in the business and indictments in order to
deliver better side to company’s original plan and strengthen future projects.
Company is focused to stay committed and in executing a bio pharmaceutical strategy
which is rich with innovative ideas (Donner, Gohier, and de Vries, 2019). Company wants to
make use of unique set of combinations in strength from large and small molecules and wants
to build immunotherapy and protein related technologies. Company has said to concentrate
their efforts, investments along with business development into some main areas such as
respiratory, inflammation and autoimmunity. The company is focussing on cardio vascular and

metabolic diseases by looking into current situations. AstraZeneca also wants to expand its
business and research in the field of oncology. The organisation has said to continue their
supplies for infections and providing vaccines in neuroscience area through their investments
and being more opportunity driven.
This business approach of AstraZeneca will help them in improving their chances of
success along with attaining their goals and increasing the funding for new projects in future.
The company believes that their future projects will come baring double the potential and
accelerating the development. The upcoming portfolio is made from efforts into progress and
will create more highlight on special care while coping up with the traditional strengths in
primary care sector. The company is also trying increasing their investments. The company is
ready to transform into using different way for their research and development (Suh,
Schnellbächer, and Heidenreich, 2020). They are also looking forward to enter into more
sustainable scientific leadership and improve their productivity. They are updating their shape
into new footprint design and evolve in their operational methods. They are expanding their
areas to bio science to bring commercial people under three different strategic centres. All these
advances will help the company to have easy collaborations with partners from external source.
AstraZeneca has underlined the commitment of bringing advanced knowledge to diseases and
forming new targets for medicine in all areas.
Resources and capabilities
Capabilities are defined as the ability of an organisation to consume available resources
in an effective way. Organisation’s resources and capabilities leads to strategic planning and
open window for many new opportunities in the market with increased support. Company can
attain competitive advantage at large scale just by determining the unique features of
organisation’s resource and capabilities (Cross, and et.al., 2021). Resources can be exploited to
get an entry in the new markets leading to the way towards more opportunities. In cases where

the organisation fails to look into resources and opportunities associated with it can help
benefitting the companies with strong hold in the market. These companies make a creative
contribution in the market. AstraZeneca is supposed to create some conditions on internal basis
which will help them produce new technological capabilities from the core subject. Current
success of the company requires having technical breakthroughs and continuous creation of
new learning process along with some insightful determination. AstraZeneca in moving towards
having more innovative strategies in order to improve their capabilities.
AstraZeneca has reviewed their past results and analysed some new trends and
strategies which will help them attain success. From the give dynamics and needs of the market
place includes f having a competitive landscape and being up to mark for customer’s
requirements. AstraZeneca’s internal conditions make them produce new technology for
building their capabilities. Company is currently looking to satisfy requirements for innovations
(Wang, and Jie, 2020). Just like any other large firm, AstraZeneca’s resource and capabilities
are there to look for new opportunities. The organisation’s strategy can be enhanced with the
help of partnership and targeting on the skills and resources. Increasing the success rates of
new medicine and decreasing its development time can help in booming competition in the
whole of pharmaceutical industry. Resource and capabilities of AstraZeneca depends on
analysing the demands and competition.
In a big industry such as pharmaceutical industry being a successful firm depends on its
ability to forefront of the medical innovations. Customers are demanding for timely medical
supply of drugs. There is also a high costs required for performing a research and entering in
the market also comes with also of obstacles (Willigers, 2020). Considering all these points, the
required resource and capabilities in achieving success are firstly, having a commitment of
financial funds and human resources for conducting research and innovations. After this the
company is supposed to build an elaborated distribution channel and thus establishing a strong

brand. Lastly, it is required to maintain highly qualified personnel. AstraZeneca’s resources
match with these factors leading to success.
AstraZeneca hold very impressive capabilities. These include, in research, products,
quality and funding category. This organisation is known in the entire world to have an
excellence in research on some most important medical fields. Company was honoured by
FNRS and FWO for its involvement in the oncology field and much other such recognition. This
organisation produces a wide range of products in medicines for almost all types of field of
specialisation. There drugs include for cardiovascular and metabolic diseases, infections,
oncology related areas, they have also produced many vaccines, helped in neuroscience,
respiratory conditions and even conditions related to gastrointestinal problems. Firm is providing
its services to a lot of countries. When talking about the internal sources, AstraZeneca’s internal
sources contribute to the profits and retained earnings and have grants for conducting research
and other things. Research for AstraZeneca holds value along with a unique approach. Funding
has a value and is also imitable and substitutable (Mahase, 2021). The company has also won
many awards and recognition for its valuable products. AstraZeneca has done well in the history
and it looks like the company is positioning themselves very strategically for future.
Environmental sustainability
Environmental sustainability in AstraZeneca make sure about how they can deal over any
situation while through which that could plays the important towards their patients and many
other clients. The social sustainability must be required to be followed for the organization from
which they can make sure about their strategies while through which they can make more
medicine and vaccine (Environmental sustainability in the pharmaceutical industry needs to be
addressed the most: poll, 2021). Diverse supply, high energy consumption and environmental
pollution hence, this might increased the environmental factor which might be addressed by the
industry. While for improving the processes for production and supply chain which might be

cannot have the value for ensure about the sustainability. While having the competition ways
the industry must be required to have the better option for which the industry can easily make
sure about their working area and making their business while for working with environmental
sustainability.
The idea for having the better sustainability which might be involved the environmental
and that might be contemporary societies for having the various patterns sources, growth,
consumption and use for having the better eco system for the organization (Barthold and Bloom,
2020). While through which using the theories that might be also involved some of the basic
information which might be important for having the better aspects in their environment. It might
be also have the standard against the existing institution for which the objective cannot be work
along with the having many more society for moving forwards. Economic analytics which might
be having the better option for the environmental development along with this also helps the
organization for having the concept as per the capita income flows and also make their long
term economic growth. In addition, this can be also said that eco systems must be important for
having the undervalues aspects in future and also have the better incorporated economic
discussion of their sustainability.
Systems and ecologist theory which might be involved for having the better sustainability
in the organization. Hence, there might be various ways for thinking about the competitive
advantage from the industry (Çop, Olorunsola and Alola, 2021). This might be also have the
better future aspects while through which the business that could easily take the advantage
from the design features and also have their long term system for which they can easily work.
Furthermore, that they can easily make sure about their various kinds of strategies which might
be seems to be important while for having the better aspects.
Political analytic that might be also important for having the better green project in the
organization while through which that might be easily for having the project whether which might
be the public policy implications. While for making the high level of implication which might be

also led them for having the better future development along with this also include the perfection
for having the better aspects for their industry (Iqbal, 2020). Astrazeneca have the various way
for improving their competitive from the other industry and that might be also play important role
for which the business can have the better option for knowing about the government rules and
regulation. While through which that could help the organization in having the better aspects
along with having the better future goals and objective for their organization.
The company can make sure about the various medicine which seems to be important in
their company along with this also make sure about their subjective for which they are must be
required. Moreover, the Astrazeneca have their self developed while through which that could
be easier in having the right vaccine for their patients in their industry. Controversy over the
natural which might be important for having the better argue between the organization along
with this the largely types for having the natural capital which seems to be increasingly (Pham
and et.al., 2020). The factor of production also make sure about those things which seems to be
important while through which the organization can easily understand the competitive in the
industry.
CONCLUSION
From the above report it had been concluded that key business strategies seems to be
important while through which it come to know about the company past five years plans and
their various terms. Along with this also come to know about those strategies which might be
helpful for the organization in having the proper estimation for their work and make sure about
the high positive impact in the business. It had been also explained about the resources and
capabilities which might be seems to be important while through which the company can easily
study about their five years business along with this also aligned while by using the resources
from which the company can make their growth. This has been also explained about the

environmental sustainability along with their theories form which it come to know about the
competitive in their industry.

REFERENCES
Books and Journals
Barthold, C. and Bloom, P., 2020. Denaturalizing the environment: Dissensus and the possibility
of radically democratizing discourses of environmental sustainability. Journal of
Business Ethics. 164(4). pp.671-681.
Çop, S., Olorunsola, V.O. and Alola, U.V., 2021. Achieving environmental sustainability through
green transformational leadership policy: Can green team resilience help?. Business
Strategy and the Environment. 30(1). pp.671-682.
Cross, S., and et.al., 2021. Who funded the research behind the Oxford-AstraZeneca COVID-19
vaccine?. Approximating the funding to the University of Oxford for the research and
development of the ChAdOx vaccine technology. medRxiv.
Donner, M., Gohier, R. and de Vries, H., 2019. NOAW project deliverable 5.3: Report on
Business Strategies (Doctoral dissertation, EU H2020).
Holmberg-Wright, K., Hribar, T. and Tsegai, J.D., 2017. More than money: Business strategies
to engage millennials. Business Education Innovation Journal, 9(2), pp.14-23.
Iqbal, Q., 2020. The era of environmental sustainability: Ensuring that sustainability stands on
human resource management. Global Business Review. 21(2). pp.377-391.
Mahase, E., 2021. AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh
risks, regulators conclude.
Mahase, E., 2021. How the Oxford-AstraZeneca covid-19 vaccine was made. bmj, 372.
Pham, H. and et.al., 2020. Moving towards sustainability: A theoretical design of environmental
performance measurement systems. Journal of Cleaner Production. 269. p.122273.
Suh, T., Khan, O.J., Schnellbächer, B. and Heidenreich, S., 2020. Strategic accord and tension
for business model innovation: Examining different tacit knowledge types and open
action strategies. International Journal of Innovation Management, 24(04), p.2050039.

Wang, M. and Jie, F., 2020. Managing supply chain uncertainty and risk in the pharmaceutical
industry. Health services management research, 33(3), pp.156-164.
Willigers, B., 2020. How advanced analytics create (Core) value: an example from a
pharmaceutical company, AstraZeneca. Journal of Business Analytics, 3(2), pp.122-
137.
Online
Environmental sustainability in the pharmaceutical industry needs to be addressed the most:
poll, 2021. [Online]. Available through:
<https://www.pharmaceutical-technology.com/news/environmental-sustainability-in-
the-pharmaceutical-industry-needs-to-be-addressed-the-most-poll/#:~:text=High
%20energy%20consumption%2C%20diverse%20supply,but%20also%20ensure
%20environmental%20sustainability.>